Home/Filings/4/0001213900-24-084108
4//SEC Filing

Chung Kevin 4

Accession 0001213900-24-084108

CIK 0001831868other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:47 PM ET

Size

5.3 KB

Accession

0001213900-24-084108

Insider Transaction Report

Form 4
Period: 2024-09-30
Chung Kevin
Chief Medical Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2024-09-30$4.26/sh+1,000$4,2589,435 total
Footnotes (1)
  • [F1]On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, all amounts of securities reported in this Form 4 have been adjusted to reflect the 1-for-25 reverse split.

Issuer

SeaStar Medical Holding Corp

CIK 0001831868

Entity typeother

Related Parties

1
  • filerCIK 0001949950

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:47 PM ET
Size
5.3 KB